Your browser doesn't support javascript.
loading
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.
Verheijen, R B; Swart, L E; Beijnen, J H; Schellens, J H M; Huitema, A D R; Steeghs, N.
Afiliação
  • Verheijen RB; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. r.verheijen@nki.nl.
  • Swart LE; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands.
  • Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands.
  • Schellens JHM; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Huitema ADR; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Steeghs N; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Cancer Chemother Pharmacol ; 80(6): 1171-1178, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29051995
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sarcoma / Sulfonamidas / Carcinoma de Células Renais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sarcoma / Sulfonamidas / Carcinoma de Células Renais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article